The next big specialty shift coming to ASCs

Advertisement

CMS finalized its 2027 outpatient payment rule Nov. 4, adding 619 procedures to the list of services Medicare will pay for in ambulatory surgery centers and removing 637 services from the inpatient-only list in the second year of a three-year phase-out. For ASC operators, the question now is which service lines will lead the next wave of outmigration.

Orthopedics has dominated that conversation for years. Travis Messina, CEO of Franklin, Tenn.-based Regent Surgical Health, isn’t ready to call that shift finished.

“A lot of times when people talk about the prevalence rate of total joints in an outpatient setting, they’re really talking about HOPDs,” Mr. Messina said. “So, I still think that you’re going to see a lot of total joint procedures move to actual ASCs.”

“Spine procedures are still going to be a major source of outmigration,” he added. “We have a lot of focus on orthopedics and specifically high-acuity spine procedures.”

As technology continues to advance and patient acuity rises and hospitals look to free up beds whenever possible, Mr. Messina has a different prediction for which specialties may start taking form in the ASC space next. 

“This is the one that excites me the most: general surgery, and then specifically within that, tumor resections,” he said. “There’s a lot of opportunity for oncology procedures to move to an ASC.”

While still very nascent in the ASC space, Mr. Messina offered a clinical case for why tumor resections may begin moving outpatient. 

“When you have surgical procedures for patients with cancer, it’s typically early on in the treatment. So you do your surgical treatment first, and then it’s followed up when possible with medical treatments, chemotherapies. Patients aren’t really immunocompromised until they begin their chemotherapy,” he said. “But regardless, you don’t want them getting sick. You don’t want them getting infections. You want them getting home as quickly as possible, and so that’s a major benefit that the ASC can play in their treatment plan.”

Given the complexity of oncology, there are limits to what could feasibly be performed in the ASC. 

“Obviously, if it’s spread, if it’s metastasized, then you’re going to need the appropriate setting of an acute care hospital,” Mr. Messina said.

Independent oncology groups are already moving into surgery. In Nashville, Tennessee Oncology, a member practice of the OneOncology network, added The Surgical Clinic, a general surgery group with 42 surgeons, as a surgical division in a deal announced in October 2024.

“I think that’s a testament to the opportunity that’s to come in that service line,” Mr. Messina said. 

Regent, which focuses on ASC joint ventures with health systems, is adding capacity of its own. In September, the company announced a partnership with Philadelphia-based Penn Medicine and Independence Blue Cross to build at least 18 new ASCs.

Cancer surgery in an ASC also requires a capital commitment that many centers have not yet made.

“You have to have robotic capabilities, and so we have robots in about a third of our centers, and so we’ve started doing things like prostatectomies, and so I think that will be a massive opportunity for the ASC industry going forward,” he said.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

Advertisement